Gene · 9656
Papers2,704
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,704
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HIV-1 Transcription Inhibitor 1E7-03 Decreases Nucleophosmin Phosphorylation. | Mol Cell Proteomics | 2023 | 36563749 | PubTator, text mining | PubMed |
| In silico study reveals unconventional interactions between MDC1 of DDR and Beclin-1 of autophagy. | Mol Divers | 2023 | 36482226 | PubTator, text mining | PubMed |
| Analysis of primary synchronous breast invasive ductal carcinoma and lung adenocarcinoma with next-generation sequencing: A case report. | Oncol Lett | 2023 | 36478904 | PubTator, text mining | PubMed |
| Deubiquitinase USP2 stabilizes the MRE11-RAD50-NBS1 complex at DNA double-strand break sites by counteracting the ubiquitination of NBS1. | J Biol Chem | 2023 | 36436562 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| CRISPR/Cas System Toward the Development of Next-Generation Recombinant Vaccines: Current Scenario and Future Prospects. | Arab J Sci Eng | 2023 | 36185592 | PubTator, text mining | PubMed |
| DNA damage response signaling: A common link between cancer and cardiovascular diseases. | Cancer Med | 2023 | 36156462 | PubTator, text mining | PubMed |
| METTL3-mediated m6A mRNA contributes to the resistance of carbon-ion radiotherapy in non-small-cell lung cancer. | Cancer Sci | 2023 | 36114749 | PubTator, text mining | PubMed |
| CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma. | Cancer Med | 2023 | 36082960 | PubTator, text mining | PubMed |
| Histone H2A variants: Diversifying chromatin to ensure genome integrity. | Semin Cell Dev Biol | 2023 | 35331626 | PubTator, text mining | PubMed |
| Histone variant-specific post-translational modifications. | Semin Cell Dev Biol | 2023 | 35277331 | PubTator, text mining | PubMed |
| DriverMP enables improved identification of cancer driver genes. | Gigascience | 2022 | 38091511 | PubTator, text mining | PubMed |
| Genomic profiles of Indonesian colorectal cancer patients. | F1000Res | 2022 | 37125020 | PubTator, text mining | PubMed |
| The Adaptability of Chromosomal Instability in Cancer Therapy and Resistance. | Int J Mol Sci | 2022 | 36613695 | PubTator, text mining | PubMed |
| cGAS in nucleus: The link between immune response and DNA damage repair. | Front Immunol | 2022 | 36591232 | PubTator, text mining | PubMed |
| Wee1 promotes cell proliferation and imatinib resistance in chronic myeloid leukemia via regulating DNA damage repair dependent on ATM-γH2AX-MDC1. | Cell Commun Signal | 2022 | 36575478 | PubTator, text mining | PubMed |
Genome-wide distribution of histone trimethylation reveals a global impact of bisphenol A on telomeric binding proteins and histone acetyltransferase factors: a pilot study with human and in vitro data. | Clin Epigenetics | 2022 | 36572933 | PubTator, text mining | PubMed |
| Arabidopsis γ-H2A.X-INTERACTING PROTEIN participates in DNA damage response and safeguards chromatin stability. | Nat Commun | 2022 | 36572675 | PubTator, text mining | PubMed |
| The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistance. | Front Immunol | 2022 | 36569948 | PubTator, text mining | PubMed |
| Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways. | Molecules | 2022 | 36557997 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9656/papers?page=15